ETF收评：港股通创新药ETF领涨3.88%，创50ETF富国领跌2.63%

Group 1 - The ETF market showed mixed performance, with the Hong Kong Stock Connect Innovative Drug ETF (159570) leading the gains at 3.88% [1] - Other notable gainers included the Hong Kong Stock Connect Innovative Drug ETF ICBC (159217) at 3.47% and the Hong Kong Innovative Drug ETF (159567) at 3.42% [1] - Conversely, the leading decliner was the China 50 ETF Fortune (159371) which fell by 2.63%, followed by the Gold Stock ETF Fund (159322) down 2.31% and the Gold Stock ETF Fund (159315) down 2.29% [1] Group 2 - A-share accounts can now trade Hong Kong stocks on a T+0 basis without the need for Hong Kong Stock Connect [1]